Michael Forer

Managing Director, Investments & Business Development, Europe

Mr. Forer serves as Managing Director of Investments and Business Development, Europe. Additionally, he serves as Vice Chairman and Executive Vice President, plus Chief Financial Officer pro tem, of ADC Therapeutics. Mr. Forer was a co-founder in 2001 of Rosetta Capital Limited (Rosetta), a London-based advisory and private equity firm focused on the life science sector. At Rosetta, Mr. Forer led its secondary investment strategy to acquire portfolios of private equity investments in primarily therapeutics-focused companies in Europe and North America, including backing from leading institutional investors. Mr. Forer was also responsible for the origination and execution of numerous advisory transactions for international private equity backed drug development and medical technology companies. Prior to co-founding Rosetta, Mr. Forer was a member of the life science private equity investment team at London-based Rothschild Asset Management (Rothschild), where his activities included origination, execution, and management of private equity investments in the global life science sector. During his tenure at Rothschild, the team made numerous investments, achieved more than two hundred million dollars in divestments, and the Rothschild portfolio grew to more than $1 billion in value. Mr. Forer was called to the Bar for the Law Society of Upper Canada after being at a leading Canadian law firm — now Ogilvy Renault — specializing in the areas of business, transactional, and securities law. He is also a former board member of Medical Devices Canada, the trade and lobby association in Canada. Mr. Forer has a Bachelor of Arts in Economics from the University of Western Ontario, a Diploma in International Business from the University of Copenhagen, and a Bachelor of Laws from the University of British Columbia.